• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23808 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     HAYES, Inc. Stereotactic radiosurgery for arteriovenous malformations and intracranial tumors
2009     NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2009     Committee for New Health Technology Assessment (CNHTA) [Tonsillectomy with coblation]
2009     Medical Advisory Secretariat (MAS) Diabetes strategy evidence platform: summary of evidence-based analyses
2009     NIHR Horizon Scanning Centre (NIHR HSC) Agento I.C for ventilator associated pneumonia
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Fast-track surgery and enhanced recovery after surgery (ERAS) programs
2009     Committee for New Health Technology Assessment (CNHTA) [Pressure wire]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies : appropriate admission explicit criteria for heart failure (HF)]
2009     Medical Advisory Secretariat (MAS) Prevention and management of pressure ulcers: summary of evidence-based analyses
2009     NIHR Horizon Scanning Centre (NIHR HSC) Radachlorin photodynamic therapy for basal cell carcinoma
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Endoscopic thoracic sympathectomy
2009     Committee for New Health Technology Assessment (CNHTA) [TruScreen - cervical cancer screening system]
2009     Medical Advisory Secretariat (MAS) Intraocular lenses for the treatment of age-related cataracts: an evidence-based analysis
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Neoadjuvant radiochemotherapy for rectal cancer
2009     Committee for New Health Technology Assessment (CNHTA) [MUTYH gene mutation[Sequencing]]
2009     Medical Advisory Secretariat (MAS) Phakic intraocular lenses for the treatment of low to high refractive errors: an evidence-based analysis
2009     Belgian Health Care Knowledge Centre (KCE) Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: Rapid assessment
2009     Committee for New Health Technology Assessment (CNHTA) [ELA2 gene point mutation analysis]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Effectiveness, safety and indications of da Vinci Surgical System]
2009     Medical Advisory Secretariat (MAS) Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [NTRK1 gene point mutation analysis]
2009     Haute Autorite de sante (HAS) [Assessment of drug-eluting stents]
2009     Medical Advisory Secretariat (MAS) Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [CoaguChek XS PT TEST]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review and cost-effectiveness analysis of radiofrequency ablation in liver tumors and metastases]
2009     Medical Advisory Secretariat (MAS) Oral appliances for obstructive sleep apnea: an evidence-based analysis
2009     NIHR Health Technology Assessment programme Adalimumab for the treatment of moderate to severe psoriatic arthritis
2009     Committee for New Health Technology Assessment (CNHTA) [AMH]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of the re-designed diagnosis process for colorectal cancer]
2009     Medical Advisory Secretariat (MAS) Fenestrated endovascular grafts for the repair of juxtarenal aortic aneurysms: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [Genotyping of MDM2 SNP309 polymorphism]
2009     Medical Advisory Secretariat (MAS) OHTAC 2009 Progress Report - advancing health: evidence-based advice on health technology
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Efficacy and safety of 64-multislice CT: a systematic review]
2009     Medical Advisory Secretariat (MAS) Intrastromal corneal ring implants for corneal thinning disorders: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [ERCC1 RNA RT-PCR quantification]
2009     Quality Improvement Scotland (NHS QIS ) Is patient self-monitoring (including self-testing and selfmanagement) of oral anticoagulation therapy safe, efficacious and cost-effective?
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Standards for the appropriate use of health technologies. Pharmacological treatment of bipolar disorder]
2009     Penn Medicine Center for Evidence-based Practice (CEP) Early term induction of labor
2009     Committee for New Health Technology Assessment (CNHTA) [RRM1 RNA RT-PCR quantification]
2009     Quality Improvement Scotland (NHS QIS ) Provision of information to patients with long term conditions
2009     Committee for New Health Technology Assessment (CNHTA) [Balloon tamponade for postpartum hemorrhage]
2009     Quality Improvement Scotland (NHS QIS ) A systematic narrative review of quality improvement models in health care
2009     HAYES, Inc. Intravitreal bevacizumab (Avastin; Genentech Inc.) for the treatment of proliferative diabetic retinopathy
2009     Committee for New Health Technology Assessment (CNHTA) [Endobronchial ultrasound/fine needle aspiration]
2009     Quality Improvement Scotland (NHS QIS ) Clinical and cost-effectiveness of self-monitoring of blood glucose (SMBG) for non-insulin treated type 2 diabetes
2009     VA Technology Assessment Program (VATAP) Systematic reviews for localized prostate cancer
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of two different strategies to implement the NVOG guideline programme on subfertility]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Is biomedical research a good social investment? The evaluation of the social impact of medical research
2009     HAYES, Inc. Breast-specific gamma imaging (BSGI)
2009     Committee for New Health Technology Assessment (CNHTA) [SurePATH liquid-based cytology test for FNA(fine needle aspiration) specimens]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Multiple chemical hypersensibility: state of the art on aetiology and treatment
2009     Committee for New Health Technology Assessment (CNHTA) [Antroduodenal manometry]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®) for the treatment of HIV-1 infected, treatment-naïve adults in combination with other antiretroviral medicinal products
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Costs and effects of two modes for disease management of chronic obstructive pulmonary disease (COPD) in general practice. A randomized controlled trial comparing regular nurse practitioner review and self-management education]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Amotosalen (Intercept) for the inactivation of pathogens in plasma and platelets: usage in Spain
2009     HAYES, Inc. Laparoscopic ileal interposition and sleeve gastrectomy for treatment of type 2 diabetes [REVISED 02.16.09]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Degarelix (Firmagon®) for the treatment of advanced hormone-dependent prostate cancer
2009     HAYES, Inc. Amyotrophic Lateral Sclerosis (ALS; Lou Gehrig Disease)
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Development of organizational interventions to improve compliance with guidelines on depression and anxiety in primary care]
2009     Penn Medicine Center for Evidence-based Practice (CEP) Managing the difficult airway
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ranolazine (Ranexa®) as add-on therapy for symptomatic treatment of stable angina pectoris
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Emerging technologies (part 2): EU newsletter
2009     HAYES, Inc. Laparoscopic sleeve gastrectomy for super obesity in adults
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Methoxy polyethylene glycol-epoetin beta (Mircera®)
2009     National Evidence-based Healthcare Collaborating Agency (NECA) [Reuse of single-use medical devices: current evidence and regulations]
2009     HAYES, Inc. Breast cancer susceptibility 1 and 2 (BRCA1/2) sequence variant testing for susceptibility to hereditary breast cancer
2009     Agency for Healthcare Research and Quality (AHRQ) Impact of consumer health informatics applications
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in CHF management programmes. Organizational challenges and evidence status]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Mecasermin (Increlex®)
2009     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009     Agency for Healthcare Research and Quality (AHRQ) Treatment of overactive bladder in women
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in mental health (Telepsychiatry)]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Filgrastim (Ratiograstim®) for the treatment of neutropenia
2009     NIHR Health Technology Assessment programme Prostate trials office (PROTO): co-ordinating trials of new technologies in the treatment of BPH
2009     Committee for New Health Technology Assessment (CNHTA) [Cardio detect(h-FABP)]
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Physical disease in schizophrenia: systematic review and analysis of hospital records]
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment of cerebrovascular disease]
2009     Committee for New Health Technology Assessment (CNHTA) [PDGFRA gene exon 12,18 mutation sequencing test]
2009     Agency for Healthcare Research and Quality (AHRQ) Diagnosis and management of ductal carcinoma in situ (DCIS)
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Transient elastography (Fibroscan) for the diagnosis of liver fibrosis: a systematic review and meta-analysis]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Quetiapine prolonged-release tablets (Seroquel XL®) for the treatment of schizophrenia in adults
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [FDG-PET for avoidance of futile direct laryngoscopies under general anaesthesia with taking of biopsies in patients with suspicion on recurrent laryngeal carcinoma after radiotherapy]
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment of cerebrovascular disease]
2009     HAYES, Inc. AlloDerm regenerative tissue matrix (LifeCell Corp.) for postmastectomy breast reconstruction
2009     Committee for New Health Technology Assessment (CNHTA) [Autologous noncultured epidermal cellular transplantation]
2009     Agency for Healthcare Research and Quality (AHRQ) Treatment of common hip fractures
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [The effectiveness of Positron Emission Tomography (PET) with 18FDG in breast cancer. A systematic review and meta-analysis]
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Etravirine (Intelence®) for the treatment of HIV-1 infected, antiretroviral treatment-experienced adults in combination with a boosted protease inhibitor and other antiretroviral medicinal products
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Foetal growth retardation at term: induction of labour or not? A comparison of maternal and neonatal outcome, maternal quality of life and costs (DIGITAT). The Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT)]
2009     HAYES, Inc. COL1A1 and COL1A2 gene testing for osteogenesis imperfecta types I to IV
2009     HAYES, Inc. Hippotherapy for Neuromusculoskeletal Dysfunction
2009     Committee for New Health Technology Assessment (CNHTA) [Anti-Heparin/Platelet Factor 4 antibody assey]
2009     Agency for Healthcare Research and Quality (AHRQ) Vitamin D and calcium: a systematic review of health outcomes
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ropinirole prolonged-release (Requip XL®) for the treatment of idiopathic Parkinson's disease
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis on depression]
2009     HAYES, Inc. Continuous renal replacement therapy (CRRT) versus sustained low-efficiency daily dialysis (SLED) for adults with non-trauma-related acute renal failure
2009     Committee for New Health Technology Assessment (CNHTA) [Intrastromal corneal ring surgery]
2009     Agency for Healthcare Research and Quality (AHRQ) Outcomes of community health worker interventions
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Paricalcitol (Zemplar®) capsules for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency